NASDAQ:CAPR
$4.51
(
-3.01%
)
Friday, 26th May 2023
Capricor Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $3.70 | $4.90 | Friday, 26th May 2023 CAPR stock ended at $4.51. This is 3.01% less than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 7.04% from a day low at $4.41 to a day high of $4.72. |
| 90 days | $3.70 | $5.22 | |
| 52 weeks | $3.30 | $6.58 |
Historical Capricor Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $4.46 | $4.72 | $4.41 | $4.51 | 83 136 |
| 2023-05-25 | $4.67 | $4.75 | $4.64 | $4.65 | 33 063 |
| 2023-05-24 | $4.72 | $4.75 | $4.61 | $4.69 | 87 314 |
| 2023-05-23 | $4.70 | $4.90 | $4.68 | $4.74 | 61 873 |
| 2023-05-22 | $4.51 | $4.74 | $4.50 | $4.66 | 69 251 |
| 2023-05-19 | $4.60 | $4.72 | $4.30 | $4.50 | 112 056 |
| 2023-05-18 | $4.34 | $4.67 | $4.34 | $4.62 | 138 490 |
| 2023-05-17 | $4.17 | $4.38 | $4.17 | $4.35 | 29 672 |
| 2023-05-16 | $4.08 | $4.30 | $4.02 | $4.24 | 22 929 |
| 2023-05-15 | $4.00 | $4.20 | $3.95 | $4.19 | 40 385 |
| 2023-05-12 | $4.08 | $4.16 | $3.94 | $4.03 | 62 000 |
| 2023-05-11 | $4.01 | $4.15 | $4.01 | $4.11 | 29 212 |
| 2023-05-10 | $4.15 | $4.15 | $4.04 | $4.08 | 26 774 |
| 2023-05-09 | $3.85 | $4.17 | $3.82 | $4.03 | 89 634 |
| 2023-05-08 | $3.95 | $3.96 | $3.79 | $3.90 | 34 469 |
| 2023-05-05 | $3.85 | $3.99 | $3.75 | $3.92 | 77 336 |
| 2023-05-04 | $3.81 | $3.92 | $3.77 | $3.77 | 29 708 |
| 2023-05-03 | $3.78 | $3.95 | $3.77 | $3.84 | 37 617 |
| 2023-05-02 | $3.92 | $3.92 | $3.70 | $3.76 | 50 961 |
| 2023-05-01 | $3.87 | $4.01 | $3.87 | $3.91 | 38 713 |
| 2023-04-28 | $3.88 | $3.95 | $3.85 | $3.89 | 35 432 |
| 2023-04-27 | $3.98 | $3.99 | $3.82 | $3.88 | 53 629 |
| 2023-04-26 | $3.96 | $3.97 | $3.86 | $3.95 | 77 768 |
| 2023-04-25 | $4.03 | $4.06 | $3.91 | $3.93 | 67 930 |
| 2023-04-24 | $4.13 | $4.19 | $3.92 | $4.07 | 94 979 |
| 2023-04-21 | $4.15 | $4.19 | $4.05 | $4.12 | 60 015 |
| 2023-04-20 | $4.20 | $4.29 | $4.13 | $4.14 | 91 134 |
| 2023-04-19 | $4.21 | $4.29 | $4.20 | $4.23 | 35 955 |
| 2023-04-18 | $4.29 | $4.30 | $4.20 | $4.22 | 54 297 |
| 2023-04-17 | $4.32 | $4.39 | $4.23 | $4.29 | 101 845 |
| 2023-04-14 | $4.30 | $4.39 | $4.21 | $4.38 | 67 329 |
| 2023-04-13 | $4.24 | $4.29 | $4.14 | $4.25 | 41 828 |
| 2023-04-12 | $4.24 | $4.35 | $4.24 | $4.24 | 40 921 |
| 2023-04-11 | $4.27 | $4.32 | $4.20 | $4.29 | 66 488 |
| 2023-04-10 | $4.29 | $4.29 | $4.15 | $4.24 | 73 495 |
| 2023-04-06 | $4.15 | $4.25 | $4.13 | $4.18 | 41 525 |
| 2023-04-05 | $4.11 | $4.29 | $4.07 | $4.19 | 70 977 |
| 2023-04-04 | $4.18 | $4.19 | $4.11 | $4.17 | 30 305 |
| 2023-04-03 | $4.22 | $4.42 | $4.17 | $4.21 | 75 165 |
| 2023-03-31 | $4.28 | $4.32 | $4.18 | $4.22 | 17 992 |
| 2023-03-30 | $4.15 | $4.34 | $4.15 | $4.31 | 65 580 |
| 2023-03-29 | $4.15 | $4.30 | $4.04 | $4.17 | 108 494 |
| 2023-03-28 | $4.10 | $4.16 | $4.01 | $4.10 | 39 591 |
| 2023-03-27 | $4.20 | $4.27 | $4.07 | $4.11 | 58 051 |
| 2023-03-24 | $4.13 | $4.27 | $4.06 | $4.12 | 83 363 |
| 2023-03-23 | $4.31 | $4.40 | $4.18 | $4.19 | 49 705 |
| 2023-03-22 | $4.50 | $4.50 | $4.28 | $4.28 | 50 004 |
| 2023-03-21 | $4.64 | $4.64 | $4.40 | $4.40 | 55 170 |
| 2023-03-20 | $4.45 | $4.57 | $4.32 | $4.48 | 85 115 |
| 2023-03-17 | $4.56 | $4.57 | $4.26 | $4.34 | 128 065 |
About Capricor Therapeutics
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph... CAPR Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
